Unveiling the underestimated prevalence of HIV, HBV and TB triple infection in Asia, South America, and Africa: a systematic review and meta-analysis
Open Access
- 20 December 2025
- journal article
- review article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Abstract
Background: Human immunodeficiency virus (HIV) is a genus of retroviruses that targets immune cells and may eventually cause immune-deficiency illness. Triple infection of HIV/hepatitis B virus (HBV) /tuberculosis (TB) leads to a worse prognosis than mono-infection. We aimed to unveil the pooled estimation of HIV/HBV/TB co-infection prevalence in Asia, South America, and Africa. Methods: A systematic literature search in PubMed, Embase, and the Cochrane Library was performed for studies of the prevalence of HIV/HBV/TB triple infection published from January 1, 1990, to March 31, 2024. The Freeman–Tukey random effects model was used to calculate the pooled prevalence. Results: We included 7 studies with in total 6401 participants and 259 triple infection cases. The pooled triple infection rate in the enrolled population was 4.4% (259/6401; 95% CI 2.2%-7.3%). The results of the subgroup analysis showed that the prevalence of triple infection was significantly higher in the South America (82/950, 8.6%; 95% CI 6.8%-10.4%), in men (86/1817, 3.4%; 95% CI 0.7%-7.8%) and patients receiving antiretroviral treatment (125/1611, 7.4%; 95% CI 5.8%–9.2%). However, no significant difference in the triple infection rate was observed among individuals initially diagnosed with HIV or TB. Conclusions: This meta-analysis suggests that the prevalence of HIV/HBV/TB triple infection in the regions studied is underestimated, and we should focus more effort on improving novel strategies for identifying triple infection of HIV/HBV/TB. However, additional studies are required to be incorporated in future analyses to provide a pooled estimate of the global pooled prevalence. Clinical trial: Not applicable.Keywords
Funding Information
- National Natural Science Foundation of China (82002243)
- Key Projects of the Beijing Municipal Education Commission's Science and Technology Plan (KZ202010025035)
- Special key research project of capital health development scientific research (SF2020-1-1151)
- Beijing Talents Fund (2018000021469G289)
- Beijing Hospitals Authority Youth Programme (QML20201702)
- The Beijing Municipal Institute of Public Medical Research Development and Reform Pilot Project (JYY2021-10)
- Talent Cultivation plan of "Climbing the peak" of Beijing Municipal Hospital Administration (DFL20221503)
- High-level Public Health Technical Personnel Construction Project (Subject leaders-02-13)
This publication has 37 references indexed in Scilit:
- Tuberculosis and HIV coinfection: Progress and challenges towards reducing incidence and mortalityInternational Journal of Infectious Diseases, 2025
- “The end TB strategy” pathway in South America: out of track for 2025 milestones and 2035 eradicationThe Lancet Regional Health - Americas, 2025
- The HIV epidemic: global and United Kingdom trendsMedicine, 2022
- A pandemic anniversary: 40 years of HIV/AIDSThe Lancet, 2021
- Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virusInternational Journal of Infectious Diseases, 2014
- Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisThe Lancet Respiratory Medicine, 2014
- Testing the Newcastle Ottawa Scale showed low reliability between individual reviewersJournal of Clinical Epidemiology, 2013
- Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, BrazilJournal of Clinical Virology, 2012
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Hepatitis B: global importance and need for controlVaccine, 1990